Novel protective effects of stem cell factor in a murine model of acute septic peritonitis -: Dependence on MCP-1

被引:24
作者
Bone-Larson, CL
Hogaboam, CM
Steinhauser, ML
Oliveira, SHP
Lukacs, NW
Strieter, RM
Kunkel, SL
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
[2] Univ Calif Los Angeles, Dept Pulm & Crit Care Med, Los Angeles, CA USA
关键词
D O I
10.1016/S0002-9440(10)64633-0
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Mast cells participate in the host response during sepsis and have been shown to have a protective effect in a murine model of acute septic peritonitis and multi-organ failure initiated by cecal ligation and puncture (CLP). Stem cell factor (SCF) is a hematopoietic cytokine important in mast cell proliferation and activation. In the present study, we examined the protective effects of a single Intraperitoneal injection of SCF given 2 hours before CLP surgery in mice. Four days after the CLP surgery, SCF pretreatment significantly improved mouse survival from 29 to 56% and mast cells were absolutely required for this effect. Immunoneutralization studies revealed that the SCF-stimulated release of monocyte chemoattractant protein-1 (MCP-1) into the septic peritoneal cavity contributed to the protective effect of SCF in this model One potential cellular source of MCP-1 was the SCF-activated mast cell. In addition, SCF pretreatment significantly augmented circulating levels of SCF and the immunomodulatory cytokine interleukin-10 in septic mice, in part because the SCF pretreatment seemed to promote the release of both mediators from the Liver. Additional hepatic effects of SCF treatment included an accelerated expression of hepatic levels of signal transducer and activator of transcription-3 (STAT-S) in CLP mice pretreated with SCF, Taken together, the findings from the present study demonstrate that the intraperitoneal delivery of SCF has a major protective effect in a murine model of CLP.
引用
收藏
页码:1177 / 1186
页数:10
相关论文
共 36 条
  • [1] Ajuebor MN, 1999, J IMMUNOL, V162, P1685
  • [2] Intrahepatic STAT-3 activation and acute phase gene expression predict outcome after CLP sepsis in the rat
    Andrejko, KM
    Chen, JD
    Deutschman, CS
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1998, 275 (06): : G1423 - G1429
  • [3] INTERLEUKIN-10 PROTECTS MICE AGAINST STAPHYLOCOCCAL-ENTEROTOXIN B-INDUCED LETHAL SHOCK
    BEAN, AGD
    FREIBERG, RA
    ANDRADE, S
    MENON, S
    ZLOTNIK, A
    [J]. INFECTION AND IMMUNITY, 1993, 61 (11) : 4937 - 4939
  • [4] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [5] INTERLEUKIN-10 (IL-10) INHIBITS THE RELEASE OF PROINFLAMMATORY CYTOKINES FROM HUMAN POLYMORPHONUCLEAR LEUKOCYTES - EVIDENCE FOR AN AUTOCRINE ROLE OF TUMOR-NECROSIS-FACTOR AND IL-1-BETA IN MEDIATING THE PRODUCTION OF IL-8 TRIGGERED BY LIPOPOLYSACCHARIDE
    CASSATELLA, MA
    MEDA, L
    BONORA, S
    CESKA, M
    CONSTANTIN, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) : 2207 - 2211
  • [6] COLEMAN JW, 1993, J IMMUNOL, V150, P556
  • [7] Critical protective role of mast cells in a model of acute septic peritonitis
    Echtenacher, B
    Mannel, DN
    Hultner, L
    [J]. NATURE, 1996, 381 (6577) : 75 - 77
  • [8] ECHTENACHER B, 1990, J IMMUNOL, V145, P3762
  • [9] Coexpression of stem cell factor and c-kit in embryonic and adult liver
    Fujio, K
    Hu, ZY
    Evarts, RP
    Marsden, ER
    Niu, CH
    Thorgeirsson, SS
    [J]. EXPERIMENTAL CELL RESEARCH, 1996, 224 (02) : 243 - 250
  • [10] FUJIO K, 1994, LAB INVEST, V70, P511